NIH-funded study finds circular RNA blood test outperforms leading diagnostic for predicting Alzheimer's progression
Summary
A new NIH-funded study has identified circular RNAs (circRNAs) in the blood as a novel biomarker for Alzheimer's disease. Elevated levels of certain circRNAs nearly tripled patients' risk of developing Alzheimer's symptoms, outperforming the current leading diagnostic blood test at predicting disease progression. This discovery could enable earlier detection and intervention before symptoms appear.
Source
Twitter / XNIH-funded study finds circular RNA blood test outperforms leading diagnostic for predicting Alzheimer's progressionnih.govKey quotes
· 3 pulledSmall loops of genetic material may be strong indicators of imminent Alzheimer's disease symptoms.
Elevated levels of certain circular RNAs (circRNAs) in the blood nearly tripled patients' risk of developing symptoms.
A novel biomarker beats the leading diagnostic blood test at predicting disease progression.
You might also wanna read
https://doi.org/10.1126/science.aeb6987
The Unintended Harms of Alzheimer's Biomarker Testing: Why Amyloid Isn't a Diagnosis
This article critically examines the growing trend of Alzheimer's Disease biomarker testing, arguing that testing for amyloid plaques does n
abpp.org·1mo agoBlood Test Breakthrough Offers Hope for Earlier Alzheimer's Detection
Researchers Announce Potential 2024 Release of Groundbreaking Alzheimer's Blood Test
Newborns have elevated levels of a biomarker for Alzheimer's
Experimental blood test detects multiple dementia types with 92% accuracy
Researchers have developed an experimental blood test that measures 15 proteins to help diagnose four major neurodegenerative diseases — Alz
sciencenews.org·17d agoExperimental blood test detects multiple dementia types with 92% accuracy
Researchers have developed an experimental blood test that measures 15 proteins to help diagnose four major neurodegenerative diseases — Alz
sciencenews.org·17d agoExperimental blood test detects multiple dementia types with 92% accuracy
Researchers have developed an experimental blood test that measures 15 proteins to help diagnose four major neurodegenerative diseases — Alz
sciencenews.org·17d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.